JNJ Johnson & Johnson · Healthcare
1 research call since Oct 14. Latest view: Neutral
Last close
$268.73 2026-10-27
Latest call vs SPY
+9.2% since 2026-10-13
Next earnings
2027-01-26 AMC
Technical scan
Hold rank 73 of 127
Price, last 12 months daily close · markers are published calls
200.00 250.00 2025-10-27 2026-04-29 2026-10-27 Neutral · Oct 14, 2026 2025-10-27: 187.02 2025-10-28: 183.71 2025-10-29: 183.39 2025-10-30: 185.80 2025-10-31: 185.62 2025-11-03: 183.05 2025-11-04: 183.64 2025-11-05: 182.80 2025-11-06: 183.75 2025-11-07: 183.36 2025-11-10: 185.17 2025-11-11: 190.49 2025-11-12: 191.04 2025-11-13: 191.89 2025-11-14: 192.56 2025-11-17: 196.14 2025-11-18: 196.56 2025-11-19: 199.02 2025-11-20: 199.57 2025-11-21: 200.39 2025-11-24: 202.50 2025-11-25: 204.40 2025-11-26: 205.28 2025-11-28: 204.65 2025-12-01: 203.09 2025-12-02: 203.17 2025-12-03: 203.08 2025-12-04: 200.26 2025-12-05: 199.71 2025-12-08: 199.41 2025-12-09: 197.77 2025-12-10: 204.27 2025-12-11: 207.70 2025-12-12: 209.26 2025-12-15: 211.82 2025-12-16: 207.00 2025-12-17: 208.02 2025-12-18: 206.02 2025-12-19: 204.10 2025-12-22: 205.04 2025-12-23: 203.52 2025-12-24: 205.50 2025-12-26: 205.35 2025-12-29: 205.28 2025-12-30: 204.64 2025-12-31: 204.68 2026-01-02: 205.07 2026-01-05: 202.07 2026-01-06: 202.54 2026-01-07: 205.21 2026-01-08: 203.49 2026-01-09: 202.15 2026-01-12: 207.42 2026-01-13: 211.30 2026-01-14: 216.15 2026-01-15: 217.16 2026-01-16: 216.26 2026-01-20: 215.81 2026-01-21: 215.62 2026-01-22: 216.09 2026-01-23: 217.72 2026-01-26: 219.06 2026-01-27: 221.98 2026-01-28: 225.22 2026-01-29: 224.80 2026-01-30: 224.76 2026-02-02: 228.22 2026-02-03: 230.54 2026-02-04: 231.90 2026-02-05: 235.18 2026-02-06: 237.36 2026-02-09: 236.02 2026-02-10: 235.73 2026-02-11: 238.22 2026-02-12: 241.87 2026-02-13: 240.78 2026-02-17: 240.66 2026-02-18: 242.30 2026-02-19: 244.20 2026-02-20: 239.83 2026-02-23: 243.14 2026-02-24: 244.87 2026-02-25: 243.77 2026-02-26: 242.08 2026-02-27: 247.01 2026-03-02: 247.14 2026-03-03: 245.34 2026-03-04: 243.90 2026-03-05: 238.26 2026-03-06: 239.03 2026-03-09: 241.20 2026-03-10: 242.32 2026-03-11: 241.60 2026-03-12: 240.66 2026-03-13: 240.14 2026-03-16: 241.80 2026-03-17: 236.75 2026-03-18: 235.92 2026-03-19: 236.24 2026-03-20: 234.02 2026-03-23: 234.07 2026-03-24: 233.92 2026-03-25: 238.56 2026-03-26: 237.87 2026-03-27: 239.08 2026-03-30: 241.10 2026-03-31: 243.04 2026-04-01: 242.72 2026-04-02: 241.65 2026-04-06: 239.59 2026-04-07: 237.05 2026-04-08: 239.92 2026-04-09: 239.93 2026-04-10: 237.10 2026-04-13: 236.60 2026-04-14: 238.73 2026-04-15: 237.31 2026-04-16: 233.20 2026-04-17: 232.84 2026-04-20: 229.37 2026-04-21: 224.87 2026-04-22: 224.81 2026-04-23: 229.33 2026-04-24: 226.20 2026-04-27: 224.05 2026-04-28: 226.49 2026-04-29: 227.35 2026-04-30: 229.85 2026-05-01: 227.19 2026-05-04: 224.20 2026-05-05: 225.55 2026-05-06: 224.62 2026-05-07: 222.51 2026-05-08: 221.32 2026-05-11: 221.43 2026-05-12: 224.26 2026-05-13: 230.42 2026-05-14: 230.80 2026-05-15: 226.71 2026-05-18: 228.92 2026-05-19: 230.00 2026-05-20: 229.32 2026-05-21: 231.73 2026-05-22: 234.34 2026-05-26: 230.18 2026-05-27: 231.29 2026-05-28: 230.80 2026-05-29: 225.33 2026-06-01: 223.51 2026-06-02: 222.89 2026-06-03: 223.24 2026-06-04: 228.17 2026-06-05: 232.77 2026-06-08: 232.16 2026-06-09: 237.00 2026-06-10: 238.49 2026-06-11: 238.33 2026-06-12: 240.87 2026-06-15: 235.66 2026-06-16: 235.18 2026-06-17: 234.20 2026-06-18: 228.39 2026-06-22: 231.29 2026-06-23: 239.08 2026-06-24: 241.00 2026-06-25: 244.88 2026-06-26: 254.66 2026-06-29: 258.51 2026-06-30: 253.97 2026-07-01: 253.98 2026-07-02: 263.04 2026-07-06: 259.33 2026-07-07: 267.24 2026-07-08: 263.40 2026-07-09: 259.10 2026-07-10: 256.98 2026-07-13: 257.77 2026-07-14: 253.85 2026-07-15: 247.02 2026-07-16: 249.97 2026-07-17: 253.04 2026-07-20: 248.82 2026-07-21: 250.61 2026-07-22: 255.63 2026-07-23: 259.27 2026-07-24: 263.40 2026-07-27: 265.95 2026-07-28: 266.73 2026-07-29: 265.53 2026-07-30: 255.82 2026-07-31: 256.35 2026-08-03: 254.41 2026-08-04: 254.93 2026-08-05: 257.59 2026-08-06: 256.98 2026-08-07: 259.24 2026-08-10: 261.81 2026-08-11: 259.80 2026-08-12: 260.86 2026-08-13: 262.08 2026-08-14: 260.35 2026-08-17: 262.37 2026-08-18: 271.11 2026-08-19: 273.41 2026-08-20: 267.37 2026-08-21: 270.24 2026-08-24: 273.04 2026-08-25: 273.14 2026-08-26: 270.00 2026-08-27: 265.77 2026-08-28: 268.04 2026-08-31: 265.85 2026-09-01: 271.19 2026-09-02: 275.21 2026-09-03: 278.43 2026-09-04: 275.23 2026-09-08: 269.12 2026-09-09: 267.08 2026-09-10: 266.35 2026-09-11: 265.58 2026-09-14: 266.32 2026-09-15: 267.20 2026-09-16: 267.28 2026-09-17: 270.22 2026-09-18: 269.99 2026-09-21: 269.47 2026-09-22: 269.19 2026-09-23: 269.17 2026-09-24: 270.68 2026-09-25: 271.22 2026-09-28: 271.95 2026-09-29: 267.57 2026-09-30: 264.74 2026-10-01: 258.66 2026-10-02: 256.03 2026-10-05: 252.93 2026-10-06: 254.78 2026-10-07: 258.45 2026-10-08: 256.48 2026-10-09: 261.44 2026-10-12: 263.73 2026-10-13: 248.61 2026-10-14: 253.91 2026-10-15: 253.28 2026-10-16: 255.56 2026-10-19: 253.79 2026-10-20: 259.36 2026-10-21: 257.78 2026-10-22: 267.61 2026-10-23: 263.81 2026-10-26: 266.30 2026-10-27: 268.73
Current technical signals nightly scan, 2026-10-27
MACD: Bullish Momentum
OBV: Bearish Divergence (Distribution)
Notable moves days JNJ was among the market's biggest movers
2026-10-13 -5.7% Morning earnings beat · $248.61
What would change the latest view
If FY27 consensus EPS of $12.26 is cut materially (e.g., below ~$11.80) after Q4 earnings, the 'trough year' thesis fails and the multiple likely compresses further If the talc participation threshold is not met or the deal collapses, the de-risking leg of the bull case is void If Darzalex misses consensus again in Q4, treat the Q3 miss as trend, not noise If the stock holds above ~$260 on no new fundamental news within 3 months, the flush was purely technical and the dip-buy thesis worked
All calls on JNJ
JNJ
Neutral
Oct 14, 2026
· Johnson & Johnson
· evidence 7/10
Reaction overdone, but no cheap edge.
JNJ delivered a genuine operational beat (6% operational sales growth, Tremfya +68%, raised guidance) but the market correctly identified quality issues: Darzalex decelerating (+16% but below consensus), Stelara erosion (-54%), a MedTech sales miss, and Innovative Medicine margin collapsing from 44.3% to 35.4% on acquired IPR&D and mix. The guidance 'raise' only partially…
Entry $248.61 (2026-10-13)
1m vs SPY: +9.2% so far
Want a fresh deep analysis on JNJ?
We analyze it in depth and publish here, usually within about 5 minutes; leave an email and we tell you when it is ready.